![]() |
Volumn 16, Issue 1, 2001, Pages 106-110
|
Inherited myoclonus-dystonia: Evidence supporting genetic heterogeneity
a,b
|
Author keywords
D2 dopamine receptor; Dystonia; Myoclonus; Myoclonus dystonia
|
Indexed keywords
ALCOHOL;
BENZATROPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHLORDIAZEPOXIDE;
CLONAZEPAM;
CYPROHEPTADINE;
DIAZEPAM;
DOPAMINE 2 RECEPTOR;
HALOPERIDOL;
PIMOZIDE;
RISPERIDONE;
VALPROIC ACID;
AMINO ACID SUBSTITUTION;
ARTICLE;
AUTOSOMAL DOMINANT DISORDER;
CHROMOSOME 11Q;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DYSTONIA;
EVIDENCE BASED MEDICINE;
FEMALE;
GENE MUTATION;
GENE SEQUENCE;
GENETIC HETEROGENEITY;
GENETIC POLYMORPHISM;
GENETIC PREDISPOSITION;
HUMAN;
INHERITED MYOCLONUS DYSTONIA;
LINKAGE ANALYSIS;
MALE;
MUTATIONAL ANALYSIS;
MYOCLONUS;
PRIORITY JOURNAL;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
CHROMOSOMES, HUMAN, PAIR 11;
DYSTONIC DISORDERS;
FEMALE;
HUMANS;
LINKAGE (GENETICS);
MALE;
MYOCLONUS;
PEDIGREE;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
RECEPTORS, DOPAMINE D2;
|
EID: 0035241272
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/1531-8257(200101)16:1<106::AID-MDS1022>3.0.CO;2-7 Document Type: Article |
Times cited : (36)
|
References (11)
|